Atlas FDA

COBRA PzF NanoCoated Coronary Stent System

FDA premarket approval P160014/S012 · decided 2019-12-06

Approval details

PMA number
P160014
Supplement
S012
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
COBRA PzF NanoCoated Coronary Stent System
Generic name
STENT, CORONARY
Applicant
Celonova Biosciences, Inc.
Date received
2019-07-19
Decision date
2019-12-06
Days to decision
140 days
Decision code
APPR
Product code
MAF
Advisory committee
Cardiovascular
Expedited review
No
Location
San Antonio, TX
Statement
Approval for a change in the bonding method of the hypotube bond.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
EMBOZENE COLOR-ADVANCED MICROSPHERES, EMBOZENE OPAQUE (NON-COLORED) MICROSPHERES, ONCOZENE MICROSPHERES (K141209)Celonova Biosciences, Inc.2014-08-07
EMBOZENE COLOR-ADVANCED MICROSPHERES, EMBOZENE OPAQUE (NON-COLORED) MICROSPHERES (K133447)Celonova Biosciences, Inc.2014-02-24
EMBOZENE MICROSPHERES (K132675)Celonova Biosciences, Inc.2013-10-03
ONCOZENE MICROSPHERES 40UM, 2ML, ONCOZENE MICROSPHERES 75UM, 2ML, ONCOZENE MICROSPHERES 100UM, 2ML, ONCOZENE MICROSPHERE (K130307)Celonova Biosciences, Inc.2013-03-04
EMBOZENE MICROSPHERES (K073417)Celonova Biosciences, Inc.2008-12-15